FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014430246> ?p ?o ?g. }

• W3014430246 endingPage "111303" @default.
• W3014430246 startingPage "111303" @default.
• W3014430246 abstract "Mixtures of substances sharing the same molecular initiating event (MIE) are supposed to induce additive effects. The proposed MIE for azole fungicides is CYP26 inhibition with retinoic acid (RA) local increase, triggering key events leading to craniofacial defects. Valproic acid (VPA) is supposed to imbalance RA-regulated gene expression trough histone deacetylases (HDACs) inhibition. The aim was to evaluate effects of molecules sharing the same MIE (azoles) and of such having (hypothetically) different MIEs but which are eventually involved in the same adverse outcome pathway (AOP). An in silico approach (molecular docking) investigated the suggested MIEs. Teratogenicity was evaluated in vitro (WEC). Abnormalities were modelled by PROAST software. The common target was the branchial apparatus. In silico results confirmed azole-related CYP26 inhibition and a weak general VPA inhibition on the tested HDACs. Unexpectedly, VPA showed also a weak, but not marginal, capability to enter the CYP 26A1 and CYP 26C1 catalytic sites, suggesting a possible role of VPA in decreasing RA catabolism, acting as an additional MIE. Our findings suggest a new more complex picture. Consequently two different AOPs, leading to the same AO, can be described. VPA MIEs (HDAC and CYP26 inhibition) impinge on the two converging AOPs." @default.
• W3014430246 created "2020-04-10" @default.
• W3014430246 creator A5000465595 @default.
• W3014430246 creator A5003739111 @default.
• W3014430246 creator A5024601621 @default.
• W3014430246 creator A5029213430 @default.
• W3014430246 creator A5048763729 @default.
• W3014430246 creator A5049596016 @default.
• W3014430246 creator A5054032151 @default.
• W3014430246 date "2020-06-01" @default.
• W3014430246 modified "2023-09-30" @default.
• W3014430246 title "Development of an adverse outcome pathway for cranio-facial malformations: A contribution from in silico simulations and in vitro data" @default.
• W3014430246 cites W1539911956 @default.
• W3014430246 cites W1910848366 @default.
• W3014430246 cites W1952281848 @default.
• W3014430246 cites W1970318742 @default.
• W3014430246 cites W1973515414 @default.
• W3014430246 cites W1974214448 @default.
• W3014430246 cites W1980755081 @default.
• W3014430246 cites W1985716775 @default.
• W3014430246 cites W1988033722 @default.
• W3014430246 cites W1994623177 @default.
• W3014430246 cites W1997231766 @default.
• W3014430246 cites W2000370098 @default.
• W3014430246 cites W2006060882 @default.
• W3014430246 cites W2009713310 @default.
• W3014430246 cites W2011141456 @default.
• W3014430246 cites W2018298304 @default.
• W3014430246 cites W2024182737 @default.
• W3014430246 cites W2026694991 @default.
• W3014430246 cites W2028092937 @default.
• W3014430246 cites W2032817067 @default.
• W3014430246 cites W2033282739 @default.
• W3014430246 cites W2035075164 @default.
• W3014430246 cites W2046458217 @default.
• W3014430246 cites W2048269834 @default.
• W3014430246 cites W2049961455 @default.
• W3014430246 cites W2054848045 @default.
• W3014430246 cites W2056989954 @default.
• W3014430246 cites W2057801246 @default.
• W3014430246 cites W2058407724 @default.
• W3014430246 cites W2074220720 @default.
• W3014430246 cites W2082629538 @default.
• W3014430246 cites W2101672658 @default.
• W3014430246 cites W2122877713 @default.
• W3014430246 cites W2123324115 @default.
• W3014430246 cites W2126175416 @default.
• W3014430246 cites W2140523553 @default.
• W3014430246 cites W2141791819 @default.
• W3014430246 cites W2148718757 @default.
• W3014430246 cites W2149370967 @default.
• W3014430246 cites W2159829632 @default.
• W3014430246 cites W2172307204 @default.
• W3014430246 cites W2174473925 @default.
• W3014430246 cites W2337949001 @default.
• W3014430246 cites W2485653215 @default.
• W3014430246 cites W2514303887 @default.
• W3014430246 cites W2551860952 @default.
• W3014430246 cites W2615223867 @default.
• W3014430246 cites W2724336500 @default.
• W3014430246 cites W2744582966 @default.
• W3014430246 cites W2795208162 @default.
• W3014430246 cites W2895443613 @default.
• W3014430246 cites W2904973474 @default.
• W3014430246 cites W2922475577 @default.
• W3014430246 doi "https://doi.org/10.1016/j.fct.2020.111303" @default.
• W3014430246 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32251704" @default.
• W3014430246 hasPublicationYear "2020" @default.
• W3014430246 type Work @default.
• W3014430246 sameAs 3014430246 @default.
• W3014430246 citedByCount "6" @default.
• W3014430246 countsByYear W30144302462020 @default.
• W3014430246 countsByYear W30144302462022 @default.
• W3014430246 countsByYear W30144302462023 @default.
• W3014430246 crossrefType "journal-article" @default.
• W3014430246 hasAuthorship W3014430246A5000465595 @default.
• W3014430246 hasAuthorship W3014430246A5003739111 @default.
• W3014430246 hasAuthorship W3014430246A5024601621 @default.
• W3014430246 hasAuthorship W3014430246A5029213430 @default.
• W3014430246 hasAuthorship W3014430246A5048763729 @default.
• W3014430246 hasAuthorship W3014430246A5049596016 @default.
• W3014430246 hasAuthorship W3014430246A5054032151 @default.
• W3014430246 hasBestOaLocation W30144302461 @default.
• W3014430246 hasConcept C104317684 @default.
• W3014430246 hasConcept C169760540 @default.
• W3014430246 hasConcept C181199279 @default.
• W3014430246 hasConcept C185592680 @default.
• W3014430246 hasConcept C202751555 @default.
• W3014430246 hasConcept C2775905019 @default.
• W3014430246 hasConcept C2777172819 @default.
• W3014430246 hasConcept C2778186239 @default.
• W3014430246 hasConcept C2779548794 @default.
• W3014430246 hasConcept C2780315139 @default.
• W3014430246 hasConcept C2781121885 @default.
• W3014430246 hasConcept C2910206359 @default.
• W3014430246 hasConcept C55493867 @default.
• W3014430246 hasConcept C70721500 @default.
• W3014430246 hasConcept C86803240 @default.

• next